Acquisition expected to be neutral to adjusted earnings per share in 2025 – 2027 and accretive thereafter and to contribute to revenue growth beginning in 2027 “Monogram’s technology is a major leap ...

Acquisition expected to be neutral to adjusted earnings per share in 2025 – 2027 and accretive thereafter and to contribute to revenue growth beginning in 2027 WARSAW, Indiana and AUSTIN, Texas, July ...

Acquisition expected to be neutral to adjusted earnings per share in 2025 – 2027 and accretive thereafter and to contribute to revenue growth beginning in 2027 Monogram's semi- and fully autonomous ...

Zimmer Biomet Holdings, Inc. has a definitive agreement to acquire all outstanding shares of the AI-driven orthopedic robotics company Monogram Technologies Inc., an equity deal valued at $177 million ...

Zimmer Biomet Holdings ZBH recently entered into a definitive agreement to acquire Monogram Technologies Inc. MGRM, an orthopedic robotics company. Under the terms of the deal, ZBH will purchase all ...

Monogram May Market the Monogram mBôs™ TKA System, Subject to the Requirements of the Federal Food, Drug, and Cosmetic Act (the Act). The Company is Preparing for Commercialization and Evaluating ...